Miltenyi Biotec
Miltenyi Biotec home - back to start page
Home ¦ Contact ¦ Ordering ¦ Terms & conditions ¦ Legal notes ¦ Jobs ¦ Forum ¦ Business development ¦ Sitemap
Miltenyi Biotec home - back to start page
Miltenyi Biotec home - back to start page
Miltenyi Biotec
MACS® Cell SeparationMiltenyi BiotecMACS® Cell AnalysisMiltenyi BiotecMACS® Cell CultureMiltenyi BiotecMACSmolecularMiltenyi BiotecClinical ProductsMiltenyi BiotecIndustrial ServicesMiltenyi BiotecMiltenyi BiotecCustomer supportMiltenyi BiotecCompany

Miltenyi Biotec
MACS Cytokines and Growth Factors
MACS® Tools for neuroscience research
Tregs—the complete portfolio
Comprehensive Genomics Services, just send your samples…
Baxter products
MACS eNewsletter
Subscribe to the
MACS eNewsletter
for regular product information via e-mail.
Miltenyi Biotec
IFN-γ Secretion Assay - Cell Enrichment and Detection Kit
Description
Interferon gamma (IFN-γ) is predominantly secreted by activated CD8+ and CD4+ memory and effector T cells and by NK cells. It is mainly involved in the regulation of inflammatory immune responses. These T1 types of immune mechanisms are effective against intracellular pathogens and tumors. IFN-γ-secreting T cells can also be involved in immunological disorders such as autoimmune reactions.

The IFN-γ Secretion Assays enable the sensitive detection as well as enrichment of human IFN-γ-secreting cells.
Applications
Virus-specific T cells were investigated after stimulation with peptides or proteins derived from influenza virus1, CMV2,3, EBV4,5,6, HIV5,7,8,9,10, HBV11, and ADV24.
Virus-specific T cells were expanded in vitro1,2,3,5,6,9 showing highly specific and very efficient killing of target cells and have been analyzed for TCR clonotypes8,10.
IFN-γ Secretion Assays were used for the isolation and analysis of antigen-specific T cells from PBMCs after stimulation with Tetanus Toxoid1, minor histocompatibility antigens, and tumor antigens12,13,14,15. IFN-γ Secretion Assays were also used to purify and analyze tumor-specific T cells from T cell lines13,14 and for isolation of functional antigen-specific, IFN-γ-secreting T cells reacting to other tumor antigens, e.g., SSX14, CEA16, or HER217 from PBMCs or TILs (tumor infiltrating lymphocytes)14,18.
The IFN-γ Secretion Assay was used to counterstain peptide-MHC-tetramer-labeled Melan A-specific CD8+ T cells to analyze functionality of the tetramer-positive cells.12,15
The IFN-γ Secretion Assay was also used for isolation and functional characterization of allergen-specific T cells.21 Furthermore, the IFN-γ Secretion Assay was used for epitope mapping of MHC class II peptides.19
IFN-γ-secreting human NK cells were isolated using the IFN-γ Secretion Assay.20 IFN-γ Secretion Assay reagents were reported to cross-react with chimpanzee cells22, but not with rhesus macaque cells.
The IFN-γ Secretion Assays can also be used for two-color cytokine analysis9 and allows counterstaining of peptide- MHC-tetramer-labeled cells 12,15. It can also be combined with flow cytometric proliferation assays 23.
Columns
For positive selection using the IFN-γ Secretion Assay - Cell Enrichment and Detection Kit: MS, LS, or autoMACS™ Columns.
Further information
Expansion of antigen-specific cytokine-secreting T cells
[PDF; 275,4 KB]
Detection and enrichment of cytokine secreting cells from whole blood
[PDF; 141,7 KB]
Detection and enrichment of cytokine secreting cells
[PDF; 202 KB]
 
Figure 1
PBMCs from a CMV+ donor were stimulated for 16 hours with CMV lysate. The responding cells were stained and isolated according to secretion of IFN-γ using the IFN-γ Secretion Assay - Cell Enrichment and Detection Kit.
In the stimulated sample, 1292 IFN-γ-secreting CD4+ T cells were enriched per 106 CD4+ T cells using MS Columns and a MiniMACS™ Separator. In the unstimulated control sample, no IFN-γ-secreting CD4+ T cells were detected per 106 CD4+ T cells after enrichment.
Stimulated sample
A: Before enrichment
B: After enrichment
Unstimulated control
C: Before enrichment
D: After enrichment
* Percentage represents frequency among CD4+ T cells.
** Percentage represents frequency among enriched cells.
Miltenyi Biotec
Customer login
Customer login
Forgot your password?
New customer?
Get more information
My favorites
Your current favorite list is empty.
Products
IFN-γ Secretion Assay - Cell Enrichment and Detection Kit (PE), human
for 50 tests with 107 total cells
Download data sheet
130-054-201
Qty:
 

Related products
Human Cytokine Secretion Assays - Enrichment and Detection Kits
Human Cytokine Secretion Assays - Detection Kits
MACSmix Tube Rotator (#130-090-753)
CD4 Antibodies
CD8 Antibodies
MACS® Cell Analysis Reagents
MACS® Cell Stimulation Reagents
Peptide pools
MACS References
1. Brosterhus et al. (1999) Eur. J. Immunol. 29: 4053-4059.[573]
2. Bissinger et al. (2002) Exp.Hematol. 30: 1178-1184.[2158]
3. Bitmansour et al. (2002) J. Immonol.169: 1207-1218.[2675]
4. Bickham et al. (2001) J. Clin. Invest. 107: 121-130.[1035]
5. Cohen et al. (2002) Virology 304: 474-484.[2676]
6. Koehne et al. (2002) Blood 99: 1730-1740.[2713]
7. Altfeld et al. (2001) J. Immunol. 167: 2743-2752.[2495]
8. Douek et al. (2002) Nature 417: 95-98.[2320]
9. Lichterfeld et al. (2004) Blood 104: 487-494.[4329]
10. Lee et al. (2002) J. Clin. Invest. 110: 1339-1347.[2677]
11. Desombre et al. (2003) J. Immunol. Meth. 286: 167-185.[4323]
12. Meidenbauer et al. (2003) J. Immunol. 170: 2161-2169.[2678]
13. Oelke et al. (2000) Clin. Cancer Res. 6: 1997-2005.[663]
14. Ayyoub et al. (2004) J. Clin. Invest. 113: 1225-1233.[4340]
15. Pittet et al. (2001) J. Immunol. 166: 7634-7640.[1037]
16. Maerten et al. (2002) Cancer Immunol. Immunother. 51: 25-32.[2679]
17. Meyer zu Büschenfelde et al. (2001) J. Immunol. 167: 1712-1719.[1260]
18. Becker et al. (2001) Nature Med. 7: 1159-1162.[1207]
19. Novak et al. (2001) J. Immunol. 166: 6665-6670.[2663]
20. Deniz et al. (2002) Eur. J. Immunol. 2002. 32: 879-884.[1279]
21. Akdis et al. (2004) J. Exp. Med. 199: 1567-1575.[3157]
22. Meyer-Olson et al. (2003) J. Immunol. 170: 4161-4169.[4343]
23. Gutzmer et al. (2003) J. Immunol. 171: 6363-6371.[4332]
24. Feuchtinger et al. (2004) Exp. Hematol. 32: 282-289.[4334]
Miltenyi Biotec
Miltenyi Biotec
© 1999 - 2008 Miltenyi Biotec
Miltenyi Biotec